Agnieszka Mierczynska-Vasilev

Dr. Agnieszka Mierczynska-Vasilev

The Australian Wine Research Institute | AWRI, Adelaide, Australia
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
RVRahul M Visalakshan
Rahul M Visalakshan
MMMelanie MacGregor
Melanie MacGregor
SSSalini Sasidharan
Salini Sasidharan
AGArtur Ghazaryan
Artur Ghazaryan
Agnieszka Mierczynska-VasilevAgnieszka Mierczynska-Vasilev
Agnieszka Mierczynska-Vasilev
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev

14 May 2020 in Small
Verified
Journal Article
Open access
PDF file
RVRahul M Visalakshan
Rahul M Visalakshan
LGLaura E. González García
Laura E. González García
MBMercy R. Benzigar
Mercy R. Benzigar
AGArthur Ghazaryan
Arthur Ghazaryan
JSJohanna Simon
Johanna Simon
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev
Nanoparticles have become an important utility in many areas of medical treatment such as targeted drug and treatment delivery as well as imaging and diagnostics. These advances require a complete understanding of nanoparticles' fate once placed in the body. Upon exposure to blood, proteins adsorb onto the nanoparticles surface and form a protein corona, which determines the particles' biological fate. This study reports on the protein corona formation from blood serum and plasma on spherical and rod‐shaped nanoparticles. These two types of mesoporous silica nanoparticles have identical chemistry, porosity, surface potential, and size in the y‐dimension, one being a sphere and the other a rod shape. The results show a significantly larger amount of protein attaching from both plasma and serum on the rod‐like particles compared to the spheres. Interrogation of the protein corona by liquid chromatography–mass spectrometry reveals shape‐dependent differences in the adsorption of immunoglobulins and albumin proteins from both plasma and serum. This study points to the need for taking nanoparticle shape into consideration because it can have a significant impact on the fate and therapeutic potential of nanoparticles when placed in the body.

18 February 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
LGLaura E. González-García
Laura E. González-García
MMMelanie MacGregor
Melanie MacGregor
RVRahul M. Visalakshan
Rahul M. Visalakshan
ALArtur Lazarian
Artur Lazarian
ACAlex Cavallaro
Alex Cavallaro
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev
Nanoparticles are widely used for biomedical applications such as vaccine, drug delivery, diagnostics, and therapeutics. This study aims to reveal the influence of nanoparticle surface functionalization on protein corona formation from blood serum and plasma and the subsequent effects on the innate immune cellular responses. To achieve this goal, the surface chemistry of silica nanoparticles of 20 nm diameter was tailored via plasma polymerization with amine, carboxylic acid, oxazolines, and alkane functionalities. The results of this study show significant surface chemistry-induced differences in protein corona composition, which reflect in the subsequent inflammatory consequences. Nanoparticles rich with carboxylic acid surface functionalities increased the production of pro-inflammatory cytokines in response to higher level of complement proteins and decreased the number of lipoproteins found in their protein coronas. On another hand, amine rich coatings led to increased expressions of anti-inflammatory markers such as arginase. The findings demonstrate the potential to direct physiological responses to nanomaterials via tailoring their surface chemical composition.

10 April 2007 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
PDF file
Agnieszka Mierczynska-VasilevAgnieszka Mierczynska-Vasilev
Agnieszka Mierczynska-Vasilev
MMM. Mayne‐L'Hermite
M. Mayne‐L'Hermite
GBG. Boiteux
G. Boiteux
JJJ. K. Jeszka
J. K. Jeszka

1 July 2013 in Biomaterials
Verified
Journal Article
Closed access
IHIsabel Hopp
Isabel Hopp
AMAndrew Michelmore
Andrew Michelmore
LSLouise E. Smith
Louise E. Smith
DRDavid E. Robinson
David E. Robinson
Akash BachhukaAkash Bachhuka
Akash Bachhuka
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev

4 February 2016 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
SCSusan N. Christo
Susan N. Christo
Akash BachhukaAkash Bachhuka
Akash Bachhuka
KDKerrilyn R Diener
Kerrilyn R Diener
Agnieszka Mierczynska-VasilevAgnieszka Mierczynska-Vasilev
Agnieszka Mierczynska-Vasilev
JHJohn Hayball
John Hayball
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev